科研之友
微信
新浪微博
Facebook
分享链接
摘要
Lowering blood glucose levels in people with type 2 diabetes has clear benefits for preventing microvascular complications and potential benefits for reducing macrovascular complications and death. %26lt;br%26gt;Treatment needs to be individualised for each person with diabetes. This should start with selecting appropriate glucose and glycated haemoglobin targets, taking into account life expectancy and the patient%26apos;s wishes. For most people, early use of glucose-lowering therapies is warranted. %26lt;br%26gt;A range of recently available therapies has added to the options for lowering glucose levels, but this has made the clinical pathway for treating diabetes more complicated. %26lt;br%26gt;This position statement from the Australian Diabetes Society outlines the risks, benefits and costs of the available therapies and suggests a treatment algorithm incorporating the older and newer agents.
- 出版日期2014-12-15
